Tag - bullous pemphigoid

Akari Therapeutics (NASDAQ:AKTX) received FDA orphan drug designation for nomacopan for the treatment of bullous pemphigoid (BP).  BP is a severe orphan inflammatory skin disease characterized by chronic blistering of...